Board of Advisors
Dr. Annabelle Morgan, Ph.D.
Peter Faucetta Jr.
Peter Faucetta has spent most of his career as an Entrepreneur in several business verticals. Most of Peter’s entrepreneurial efforts over the past 25 years have been focused in the Print/Marketing Management Services Industry. He attended both Georgetown and American University, graduating from the School of International Service (SIS) in 1988. Originally a native of New York, Peter began his career as VP Business Development for The Kordet Group. Following asuccessful IPO of that organization (Applied Graphics Technologies) in 1995, Peter formed K2G, a pioneer in the emerging print management industry.
In 1998, Peter led a team of like Entrepreneurs in the industry through a successful Consolidated Roll-up to become Integrated Graphics International. Entering the boom of digital technologies in the late 1990’s, Peter founded NewLine Management (NLM). In 2000, Peter in association with Accel Partners Equity merged NLM with Noosh Technologies (www.noosh.com), then and today, the premier SAS Print Management technology platform. Eventually in 2005, the client management business solutions group of Noosh was acquired by InnerWorkings. Peter partnered with InnerWorkings (www.inwk.com) and had been part of the executive management team for over 10 years, charged with bringing management and innovation solutions to both National and Global client relationships which generate over 1 billion in yearly sales. He recently retired from InnerWorkings at the end of 2019.
An avid sports enthusiast, Peter is a retired pro race car driver/owner, having professionally raced from 1988- 2000 in the Toyota Atlantic Championship Series, The Indy Light Championship Series and driving for Alex Job racing in The Rolex Daytona 24 Hours.
He now spends recreational time enjoying golf, skiing and scuba diving with his family and friends.
Dr. Young Hee Ko
John Hopkins University
Khalid Matalka, Ph.D., SI(ASCP)
Chief Scientific Officer
Professor Khalid Matalka received his BSc and MSc in Medical Technology in 1986 and 1988 from Yarmouk University, Jordan, and the University of Wisconsin-Milwaukee, USA. Then he received his Ph.D. in Pathology (Immunology and Cancer therapy) from Ohio State University, USA, in 1992. After finishing his Ph.D., Dr. Matalka joined Harvard Medical School as a Postdoctoral fellow till 1994. He is an American Board Certified as a Specialist in Immunology (SI-ASCP) and a member at the American Society for Cancer Research since 1994.
Dr. Matalka enrolled in academia as an assistant professor in 1995, then promoted to associate and then a professor in 2004. Prof. Matalka held a dean position at two different academic institutions. Besides, Prof. Matalka was a consultant for twenty years to a JPM pharmaceutical company and a hospital diagnostic laboratory. During those 22 years, Prof. Matalka was heavily involved in research mainly on immunomodulation, cancer research, and development of immunological assays. In 2016, he joined a pharmaceutical startup company named OncoTherapeutica, MA as a Chief Biologist. While there, Prof. Matalka was developing new potential drugs for the treatment of prostate cancer and melanoma. In March 2020, Prof. Matalka joined Medolife Corporation as Chief Scientific Officer (CSO) and, in February 2021, became the CSO of the newly established Medolife Rx.
Prof. Matalka has 65 publications in peer-reviewed international journals, and he is an Associate Editor of two and a member of the editorial board of several international journals. Prof. Matalka is known as an international reviewer in the fields of Cancer therapy, Immunomodulation, and Ethnopharmacology.
Dr. Peter Pedersen
John Hopkins University
Head of R&D
Dr. Sahakyan started his career at Glendale Community College (GGC) as a lab technician for the biology department. He then pursued a biotechnology major at Pasadena City College (PCC). During his studies he interned at the Pasadena Bio Collaborative (PBC) Incubator as part of the LA Bioscience Hub research outreach program. Dr. Sahakyan worked with multiple companies including UCLA, Amgen and others during his summer internship. Upon completion, he was offered a permanent position at BCN (UCLA research collaborative) where he completed multiple projects, some of them are pending publication. In 2019, Dr. Sahakyan was offered a position in Medolife as a research associate. Within a year he was promoted to head scientist. Throughout this time, Dr. Sahakyan has worked on a number of company projects, which he presented at different local and national conferences. One of his bigger projects is the differentiation of embryonic stem cells into red blood cells. He continuously brings new ideas and initiatives to the company.
Advisor to CEO
Steve is a serial entrepreneur where he is currently the Founder and CEO of ASTOUNDZ, one of Houston’s leading Search Engine Optimization (SEO) and Web marketing companies. From 1997 to 2013, Steve founded and led ERGOS Technology, an outsourced IT consulting firm founded in Houston, TX. ERGOS technology provided fully managed IT services to companies ranging from 20 to 500 employees. ERGOS had over 600 companies and 15,000 desktops under management at the time of the sale. After selling and resigning his day-to-day duties at ERGOS, Steve started Chesapeake Investments where he develops and invests in residential and commercial real estate, as well as other business investments. Steve received his BA in Economics from the University of Texas in 1985 and his MBA from the University of Houston in 1992. He has served in numerous Board and volunteer roles for the University of Texas Ex-Students, for technical industry related companies and peer groups. Steve is on the development board for BBVA bank and is currently the Board Chair for AVDA, a Houston based non-profit providing free legal assistance to those afflicted with domestic abuse. Steve is married to Paula Winter and they have two boys. Steve and his family are Parishioners at St. Michael Church and members of Houston Oaks Country Club.
Dr. Michael Zhang
John Hopkins University